Christopher Robin Lowe

Co-Founder at Psynova Neurotech Ltd.

Christopher Robin Lowe

Christopher Robin Lowe

Co-Founder at Psynova Neurotech Ltd.

Overview
Career Highlights

Psynova Neurotech Ltd.
ProMetic BioSciences Ltd.

RelSci Relationships

191

Number of Boards

7

Relationships
RelSci Relationships are individuals Christopher Robin Lowe likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director of the Institute of Biotechnology at University of Cambridge

Relationship likelihood: Strong

Director at Psynova Neurotech Ltd.

Relationship likelihood: Strong

Director at Synergis Technologies Ltd.

Relationship likelihood: Strong

Professional at Synergis Technologies Ltd.

Relationship likelihood: Strong

Former Chief Investment Officer & Partner at Baillie Gifford & Co.

Relationship likelihood: Strong

Scientist at Nanoholdings LLC

Relationship likelihood: Strong

Former Chief Executive Officer at Benitec Biopharma Ltd.

Relationship likelihood: Strong

Chief Investment Officer & Executive Vice President at Portland Investment Counsel, Inc.

Relationship likelihood: Strong

Venture Partner at Draper Esprit (Private Equity)

Relationship likelihood: Strong

Founder at Dill Faulkes Educational Trust

Relationship likelihood: Strong

Paths to Christopher Robin Lowe
Potential Connections via
Relationship Science
You
Christopher Robin Lowe
Co-Founder at Psynova Neurotech Ltd.
Education
PhD in Biochemistry

Birmingham has been challenging and developing great minds for more than a century. Characterised by a tradition of innovation, research at the University has broken new ground, pushed forward the boundaries of knowledge and made an impact on people’s lives. We continue this tradition today and have ambitions for a future that will embed our work and recognition of the Birmingham name on the international stage. Universities are never complete. They develop as new challenges and opportunities occur. At Birmingham we innovate, we push the frontiers of understanding; we ask new research questions, we turn theory through experiment into practice – because that’s what great universities do.

Career History
Co-Founder
Current

Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.

Scientist
Current

Nanoholdings focuses exclusively on investments in nanotechnology-based energy solutions. The firm seeks to invest in cutting-edge nano-energy technologies that offer solutions to the world's growing energy problems. They partner with universities, scientists and corporations around the world to develop, license and commercialize those nano-energy technology innovations and to create commercially-viable products and solutions. Nanoholdings invests in ideas and companies in the early stages of development and participates in the day-to-day operating management of their portfolio companies. The firm seeks to identify and invest in companies and in the development of products and ideas with the potential to revolutionize the way energy is generated and used on a global basis.

Boards & Committees
Director
2002 - Current

Smart uses a revolutionary intelligent optical sensor technology, SHOPS™, which is a platform for a wide number of applications for use in a broad spectrum of key industry sectors. Its initial product range is deployed using holographic platforms (sensor holograms).Its primary objective is to offer their partners and end users bespoke solutions, by creating highly differentiated products and setting new industry standards.At Smart, they focus on three main markets Brand Protection, Product Verification and Medical Diagnostics. Each market is driven by different demands but in all three, their partners look to them to provide the right solution for their business and customer base.With strong IP protection and a fully operational manufacturing plant, Smart is perfectly placed to build long-term partnerships and to support the end-to-end process of developing market-ready products.

Director
2005 - Prior

Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.

Director
2000 - 2012

The Bioscience Investment Trust Plc (formerly 3i Bioscience Investment Trust) provides financial and investment services. It aims to achieve long-term capital growth by investing in life science and healthcare companies in which value growth is expected to occur through the development or application of technology. The company invests in companies including Amgen, Inc., Gilead Science, Inc., Align Technology, Inc., Acambis Plc, Shire Pharmaceuticals Group Plc, Celgene Corp., Protein Design Labs, Inc., Alizyme Plc, Gyrus Group Plc and Advanced Neuromudulation Systems, Inc. Bioscience Investment Trust Plc is headquartered in London, UK.

Director
Current

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Investments
Details Hidden

Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.

Details Hidden

Purely Proteins Ltd. provided supportive services for drug discovery. The firm also offered range of protein-based tools to aid drug discovery, research and development. The company was founded by David Bailey, Geeta Gupta, Christopher Robin Lowe and David J. Parry-Smith on July 16, 2002 and was headquartered in Madingley, the United Kingdom.

Details Hidden

Smart uses a revolutionary intelligent optical sensor technology, SHOPS™, which is a platform for a wide number of applications for use in a broad spectrum of key industry sectors. Its initial product range is deployed using holographic platforms (sensor holograms).Its primary objective is to offer their partners and end users bespoke solutions, by creating highly differentiated products and setting new industry standards.At Smart, they focus on three main markets Brand Protection, Product Verification and Medical Diagnostics. Each market is driven by different demands but in all three, their partners look to them to provide the right solution for their business and customer base.With strong IP protection and a fully operational manufacturing plant, Smart is perfectly placed to build long-term partnerships and to support the end-to-end process of developing market-ready products.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher Robin Lowe. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher Robin Lowe's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher Robin Lowe.